Indoco Remedies - U.S. To Drive Growth: Nirmal Bang
1 month ago•Bloomberg Quint
USFDA Approves Indoco Remedies’ Generic Diabetes Drug
1 month ago•Bloomberg Quint
Indoco Remedies - Resolution Of Facilities A Key Monitorable: Nirmal Bang
10 months ago•Bloomberg Quint
Buy Indoco Remedies; target of Rs 380: Prabhudas Lilladher
1 year ago•Moneycontrol
Indoco Remedies shares rise following EU GMP certification
1 year ago•The Hindu Businessline
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
1 year ago•Moneycontrol
Stocks to watch on June 12, 2023
1 year ago•The Hindu Businessline